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Introduction
Anaesthesiologists are frequently faced with patients 
suffering from perioperative cardiac events. Fortunately, 
intraoperative ST elevation is not that common. However, it 
is important to consider all possibilities when encountering 
it as incorrect assumptions may result in incorrect therapy. 
We present an interesting case of ST elevation that occurred 
soon after induction of anaesthesia.
Case study
A 61-year-old patient with no previous cardiovascular 
history was scheduled for an elective acromioplasty. 
Despite her arthropathy, she was an active patient with 
good effort tolerance. She had never experienced angina 
or palpitations, and had no family history of heart disease. 
She was a chronic smoker. She had undergone prior 
surgery in 2008 for a prolapsed bladder, and both the 
general anaesthetic and recovery were uncomplicated. 
The preoperative examination, haematological workup, 
electrocardiogram (ECG) and chest X-ray were all normal. 
An uncomplicated interscalene brachial block was 
performed using a nerve stimulator on the awake patient 
(70 mg of plain bupivacaine in a volume of 20 ml). A 
prophylactic antibiotic was given prior to induction. 
Following preoxygenation, she was induced with an elective 
sequence induction, using propofol 140 mg, vecuronium 
4 mg and fentanyl 200 µg. The intubation was uncomplicated 
and she was initiated on intermittent positive pressure 
ventilation and placed in a semi-sitting position for the 
surgery. The patient’s anaesthetic was maintained with 
sevoflurane, oxygen and air.
Five minutes after her induction, the patient became 
acutely hypotensive. The mean arterial pressure dropped 
from a preoperative value of 85 mmHg to 55 mmHg. This 
hypotension was resistant to repeated boluses of ephedrine 
and phenylephrine. An initial compensatory tachycardia of 
110 beats per minute (bpm) fell to 50 bpm, and 0.5 mg of 
atropine was given twice. The patient remained hypotensive 
and bradycardic, so 1 ml of 1:10 000 adrenaline was 
administered. There was a brief period of tachycardia, 
but both her heart rate and blood pressure subsequently 
normalised without any further inotropic support. However, 
significant ST elevation was noted on ECG monitoring. 
The elective surgery was postponed and a cardiologist 
consulted.
On review of the history and 12-lead ECG, the cardiologist 
advised urgent thrombolysis. Tenectaplase was ordered, 
but it was not readily on hand in theatre. Therefore, the 
patient was kept on the operating table and monitored. 
Serial ECGs showed complete normalisation and a return 
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to the patient’s preoperative state, 
with no evidence of any evolving 
myocardial infarction. A decision was 
made to omit thrombolysis and monitor 
her cardiovascular status in the high 
care unit (HCU) overnight. Angiogram 
facilities were not immediately available 
and the investigation was deferred until 
the following morning.
On admission to the HCU, she remained 
stable with no chest pain, nor any 
changes in her heart rate or blood 
pressure. Appropriate counselling of the 
patient and her family took place. She 
remained in the HCU for the next 48 
hours, and was treated as an ST elevation 
myocardial infarction with enoxaparin, 
clopidogrel, aspirin and simvastatin.  
Investigations
Two-hourly ECGs and six-hourly 
serological cardiac enzyme levels were 
performed in the HCU. The initial ECG, 
performed on the table following the 
patient’s period of instability, indicated 
significant ST elevation in leads II, III, 
AVF, V3, V4, V5 and V6, suggestive of 
inferiolateral infarction. Serial ECGs 
showed normalisation with intermittent 
ST elevation in the same leads, but no 
further indicators of evolving ischaemia 
as time progressed.
Cardiac markers taken two hours post 
peri-arrest state were elevated with a 
creatine kinase-MB of 51.3 U/l, and 
cardiac troponin I of 24 650 ng/l. These 
showed a downward trend over the 
next two days, suggestive of an acute 
episode of ischaemia, followed by fairly 
rapid resolution, which correlated with 
the ECGs. Further special investigations 
aimed to identify the precipitating factor 
for this episode of coronary artery 
insufficiency. Normal mast cell triptase 
and histamine levels drawn on admission 
to the HCU excluded an anaphylactoid 
reaction that may have accounted for 
the initial hypotension and subsequent 
inadequate epicardial perfusion. 
Serum chemistry showed a slightly 
low magnesium level 0.65 mmol/l. This may have been a 
contributing factor. Finally, a coronary artery angiogram 
was performed to exclude any physical obstruction to the 
vessels. It revealed normal epicardial coronary arteries 
with some apical hypokinesis, but ventricular tachycardia 
developed twice during the procedure. A diagnosis of 
coronary artery vasospasm was proposed.
ECG 1
ECG 2
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Differential diagnosis
This incident was recognised as a case of acute myocardial 
ischemia, with a subsequent ST elevation myocardial 
infarction from an early stage. Coronary artery disease 
and obstruction of a vessel by an atherosclerotic plaque 
were foremost in our minds. However, a normal angiogram 
excluded this possibility, and the patient’s rapid recovery 
suggested a dynamic obstruction to the coronary vessels, 
rather than a fixed stenosis, thus suggesting a type II 
myocardial infarction, rather than a type I, according to the 
American Heart Association classification.
Inadequate coronary perfusion then had to be evaluated. 
The potential for anaphylaxis was considered and excluded 
biochemically. Local anaesthetic toxicity, following the 
brachial block, was considered, although the regional 
technique was uncomplicated, had worked well and the 
episode of instability was too short-acting to be attributed 
to an intravascular dose of bupivacaine.
Consequently, a diagnosis of vasospasm was suggested. 
Hypercontractility of the coronary arteries was the likeliest 
cause in a patient who was a chronic smoker with low 
magnesium levels. Various precipitants experienced 
during the induction of anaesthesia may have triggered 
the vasospasm, namely the hypotension induced by the 
propofol induction, a Bezoldt-Jarisch reflex secondary to 
the positioning, the use of ephedrine, the adrenaline bolus, 
histamine release induced by the fentanyl, or even a brief 
period of hyperventilation.1 A nicotine withdrawal may also 
have contributed.2
Treatment
On diagnosis of coronary artery vasospasm, the patient’s 
anticoagulants were discontinued. It should be noted that 
the treatment of choice for an acute event of confirmed 
vasospasm is the administration of nitrates.2 This 
management option was not considered 
in the acute setting with this index patient. 
Therapies to prevent future events of 
vasospasm include the cessation of 
smoking, statin therapy, antioxidants, 
calcium-channel blockers, aspirin and 
oestrogen in postmenopausal females.3
The patient was discharged from the 
HCU after 48 hours and was monitored 
by the cardiology department. She was 
educated about the diagnosis, initiated 
on a new dietary plan and advised 
to stop smoking. She returned to her 
preoperative level of functioning. Her 
acromioplasty was postponed for six 
months.
Discussion
Coronary artery vasospasm is an uncommon diagnosis in 
the developing world. Limited cardiology services to confirm 
this diagnosis, coupled with misdiagnosis of these cases as 
forms of fixed coronary artery obstruction, seem to account 
for the under-reporting of this condition.2,4 It is a form of 
coronary artery disease that causes a sudden, transient 
narrowing of one or more of the coronary arteries. This 
differs to the chronic, progressive obliteration caused by 
atheromatous plaques described with traditional coronary 
artery disease. The temporary constriction of vessels is 
due to the hypercontractility of coronary vascular smooth 
muscle, which, in turn, is due to endothelial dysfunction 
with reduced endothelial nitric oxide activity,3 increased 
oxidative stress and chronic low-grade inflammation. Just 
as the pathophysiology of the condition differs from the 
classic picture of stenotic coronary artery disease, so too 
does the patient profile. Smoking is the single greatest risk 
factor, whereas other conditions, such as hypertension and 
diabetes, have no significant risk at all.3
Coronary artery vasospasm, while under anaesthesia, is 
by no means a novel idea in the current literature. Indeed, 
several precipitating factors for vasospasm may be unique 
to a theatre setting, including sudden hypotension induced 
by certain induction agents or neuraxial anaesthesia, 
hyperventilation, the manipulation of visceral organs during 
surgery,5 the deflation of tourniquets during orthopaedic 
procedures,6 and the administration of a combination of 
vasopressors and histamine-releasing agents.3 Yet it is a 
phenomenon that is infrequently reported, and as described 
by this case report, is a diagnosis that is settled upon when 
all else has been excluded.1 
It is appreciated that coronary vasospam is an under-
diagnosed entity, and new attention is being paid to the 
subtleties of this condition and its early recognition and 
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management. Patients who are at risk are not the typical 
overweight, middle-aged men who suffer from coronary 
artery stenosis, but rather younger patients, particularly of 
Eastern Asian origin, who are smokers.3 However, a definitive 
diagnosis is difficult in a theatre setting as angiography 
reveals normal vessels in 70% of patients who experience 
vasospasm. Intracoronary injection of acetylcholine induces 
a short-lived vasospasm that is visible on imaging in the 
affected artery or arteries.1,3 The degree of constriction may 
also be visualised. The invasive nature of the required test 
and expertise render it an on-table investigation that is far 
from ideal, but is currently the gold standard diagnostic tool.
The pathophysiology of coronary artery vasospasm entails 
that the implicated vessels have no fixed organic stenosis, 
but rather hypercontractility of the smooth muscle lining the 
vessel. Thus, the management of choice is vasodilators, and 
specifically nitrates and calcium-channel blockers, rather 
than the thrombolytics traditionally used in acute coronary 
syndrome.2 The degree of constriction of the artery and 
subsequent ischaemia varies, resulting in a spectrum of 
disease. It stands to reason to relieve the obstruction as 
soon as the vasospasm has been identified.
Conclusion
In conclusion, coronary vasospasm is a difficult diagnosis 
to make intraoperatively. However, it should be considered 
in younger patients who smoke and who do not necessarily 
fit the typical high-risk profile for cardiac ischaemic events. 
The diagnosis is usually made in the coronary catheter 
laboratory. The management of coronary vasospam is 
nitrates and calcium-channel blockers.
The following should be borne in mind:
•	 Not all coronary artery disease is an atherosclerotic 
fixed obstruction. Vasospasm is due to dynamic 
hypercontractility and constriction.
•	 The perioperative setting provides numerous precipitants 
for at-risk patients to develop vasospasm. Anaesthetists 
should be sensitive to this possibility.
•	 Nitrates and calcium-channel blockers are the managing 
agents of choice.
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